人类癌症中的T细胞耗尽
Kuan Kang1, Xin Lin1, Pan Chen2
1Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China; The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha 410008, Hunan, China; The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha 410078, Hunan, China.
消耗T细胞会损害抗癌免疫力和免疫疗法的有效性. 了解其调节机制和治疗逆转对于改善癌症治疗结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- T细胞耗尽是T细胞由于持续的抗原暴露而导致的功能障碍的状态.
- 这种状况的特点是基因表达,新陈代谢和效应器功能的改变.
- 消耗T细胞显著导致癌症免疫逃避,并限制了免疫疗法的有效性.
研究的目的:
- 提供T细胞耗尽在癌症发育和进展中的全面审查.
- 总结监管机制,包括分子和微环境因素.
- 讨论T细胞枯竭对癌症免疫疗法的挑战,并探索治疗策略.
主要方法:
- 在癌症中对T细胞耗尽的文献综述.
- 综合有关调节机制的信息 (转录因子,表观遗传学,新陈代谢,微环境).
- 分析T细胞耗尽对免疫检查点阻塞 (ICB) 和CAR-T细胞疗法的影响.
主要成果:
- T细胞疲劳涉及复杂的调节网络,包括转录因子,表观遗传修饰,代谢重编程和微环境线索.
- 它对当前的癌症免疫疗法,如ICB和CAR-T疗法,构成重大障碍.
- 目前正在开发各种治疗策略,以逆转或减轻T细胞耗尽.
结论:
- T细胞耗尽是癌症免疫和免疫治疗中的关键障碍.
- 准T细胞耗尽机制为增强抗癌疗法提供了有前途的途径.
- 对逆转T细胞枯竭的进一步研究对于改善患者的治疗结果至关重要.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Replicative Cell Senescence
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


